Skip to main content
. Author manuscript; available in PMC: 2018 Jan 31.
Published in final edited form as: Clin Neurol Neurosurg. 2015 Oct 17;139:244–246. doi: 10.1016/j.clineuro.2015.10.019

Table 1.

Demographic characteristics and screening test scores.

Group N Age (years) Male (%) HY (stage) Education (years) LEDD (mg) MMSE score MoCA score
PD-NC 32 68.6 (8.8) 63 2.5 (0.6) 13.0 (2.4) 700 (475) 29.3 (0.7) 27.8 (1.2)
PD-MCI 23 70.9 (8.2) 65 2.6 (0.8) 12.9 (1.4) 725 (314) 28.1 (1.5) 24.4 (1.4)
PD-D 8 70.5 (5.9) 75 3.1 (1.3) 12.8 (1.8) 450 (397) 24.6 (2.1) 17.6 (2.6)

PD-NC, PD patients with MoCA score ≥26; PD-MCI, PD patients with MoCA score 21–25; PD-D, PD patients with MoCA score <21; MMSE, Mini Mental State Examination; MoCA, Montreal Cognitive Assessment; HY, Hoehn and Yahr stage; LEDD, levodopa equivalent daily dose.